ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow-to-Debt Ratio
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow-to-Debt Ratio of 0.10x as of March 2026, meaning its operating cash flow of $33.98 Million could theoretically repay 0% of its total liabilities ($357.16 Million) in one year. See ACADIA Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ACADIA Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for ACADIA Pharmaceuticals Inc across 24 annual periods. Also explore ACADIA Pharmaceuticals Inc (ACAD) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ACADIA Pharmaceuticals Inc (2002–2025)
Year-by-year debt coverage analysis for ACADIA Pharmaceuticals Inc. For market capitalisation and broader financial context, see ACADIA Pharmaceuticals Inc (ACAD) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | $109.84 Million | $336.81 Million | ▼ -5.9% |
| 2024 | 0.35x | $157.72 Million | $454.96 Million | ▲ +558.4% |
| 2023 | 0.05x | $16.70 Million | $317.20 Million | ▲ +108.7% |
| 2022 | -0.61x | $-114.03 Million | $187.40 Million | ▲ +22.9% |
| 2021 | -0.79x | $-125.66 Million | $159.23 Million | ▲ +9.8% |
| 2020 | -0.88x | $-136.17 Million | $155.61 Million | ▲ +51.3% |
| 2019 | -1.80x | $-151.13 Million | $84.05 Million | ▲ +34.4% |
| 2018 | -2.74x | $-167.47 Million | $61.12 Million | ▲ +38.1% |
| 2017 | -4.43x | $-217.86 Million | $49.22 Million | ▲ +10.1% |
| 2016 | -4.92x | $-210.41 Million | $42.74 Million | ▲ +10.5% |
| 2015 | -5.50x | $-121.80 Million | $22.13 Million | ▼ -32.3% |
| 2014 | -4.16x | $-66.43 Million | $15.97 Million | ▲ +8.5% |
| 2013 | -4.55x | $-31.77 Million | $6.99 Million | ▼ -396.2% |
| 2012 | -0.92x | $-21.63 Million | $23.61 Million | ▲ +59.7% |
| 2011 | -2.27x | $-19.90 Million | $8.75 Million | ▼ -84.9% |
| 2010 | -1.23x | $-10.70 Million | $8.71 Million | ▼ -236.4% |
| 2009 | -0.37x | $-13.73 Million | $37.57 Million | ▲ +93.4% |
| 2008 | -5.55x | $-64.87 Million | $11.69 Million | ▼ -108.7% |
| 2007 | -2.66x | $-54.93 Million | $20.65 Million | ▼ -43.8% |
| 2006 | -1.85x | $-41.42 Million | $22.39 Million | ▼ -111.3% |
| 2005 | -0.88x | $-20.26 Million | $23.13 Million | ▲ +59.0% |
| 2004 | -2.14x | $-20.69 Million | $9.68 Million | ▼ -1736.3% |
| 2003 | -0.12x | $-9.82 Million | $84.36 Million | ▲ +29.4% |
| 2002 | -0.16x | $-9.24 Million | $56.11 Million | — |